It promotes invasion in hepatocellular carcinoma and epithelial–mesenchymal transition (EMT) in prostate cancer via MMP-2, MMP-7, MMP-9, and NF-κB signaling. The gene discussed is MMP9; the disease is hepatocellular carcinoma.